A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

NCT07609914 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer